从度拉鲁肽转用替扎帕肽对血糖控制、体重和脂肪肝的影响：一项回顾性研究

{"title":"从度拉鲁肽转用替扎帕肽对血糖控制、体重和脂肪肝的影响：一项回顾性研究","authors":"T. Sawamura, Ren Mizoguchi, Ai Ohmori, M. Kometani, T. Yoneda, S. Karashima","doi":"10.1007/s40200-024-01472-w","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":502893,"journal":{"name":"Journal of Diabetes & Metabolic Disorders","volume":"22 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of the switch from dulaglutide to tirzepatide on glycemic control, body weight, and fatty liver: a retrospective study\",\"authors\":\"T. Sawamura, Ren Mizoguchi, Ai Ohmori, M. Kometani, T. Yoneda, S. Karashima\",\"doi\":\"10.1007/s40200-024-01472-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":502893,\"journal\":{\"name\":\"Journal of Diabetes & Metabolic Disorders\",\"volume\":\"22 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Diabetes & Metabolic Disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40200-024-01472-w\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes & Metabolic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40200-024-01472-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}